Cattle healthcare is one of the major aspects of animal husbandry as it has direct co-relation with productivity and outcome from animal husbandry. Several countries worldwide are focusing more on the cattle health to improve the health and welfare of cattle and implementing several initiatives for the same.

Market Dynamics

Increase in burden of animal health, growing focus on cattle health, rise in demand for vaccination, involvement of the government, favorable initiatives, and increase in research and development are major factors expected to drive growth of the global cattle healthcare market.

For instance, in August 2021, the Ministry of Science and Technology, the Government of India released IndiGau, India’s first Cattle Genomic Chip for the conservation of pure varieties of cattle breeds such as Gir, Kankrej, Sahiwal, Ongole, and more. The chip is developed by the concerted efforts of scientists of National Institute of Animal Biotechnology (NAIB), Hyderabad, under the aegis of the Department of Biotechnology. Moreover, in August 2022, due to the rise of Lumpy Skin Disease in cattle in neighboring states, the Department of Animal Husbandry, Chandigarh took all preventive measures to prevent the disease in the city.

Key features of the study

• This report provides in-depth analysis of the global cattle healthcare market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cattle healthcare market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Idexx Laboratories, Boehringer Ingelheim, Virbac, Elanco, IDVet, Zoetis Inc., Bayer Healthcare, Merck & Co. Inc., and Ceva Animal Health Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cattle healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cattle healthcare market.

Market Segmentation

• By Product
  • Vaccine
  • Parasiticide
  • Anti-infective
  • Medical Feed Additive
  • Other Pharmaceuticals
• By Diagnostic Type
  • Immunodiagnostic Test
  • Molecular Diagnostics
  • Diagnostic Imaging
  • Clinical Chemistry
  • Other Veterinary Diagnostics
• By Region
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • North Africa
    • Central Africa
• Key Players
  • Idexx Laboratories
  • Boehringer Ingelheim
  • Virbac
  • Elanco
  • IDVet
  • Zoetis Inc.
  • Bayer Healthcare
  • Merck & Co. Inc.
  • Ceva Animal Health Inc.